Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Contraception

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    10,852 result(s) found for: Contraception. Displaying page 1 of 543.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2006-003387-55 Sponsor Protocol Number: 2914-004 Start Date*: 2007-11-15
    Sponsor Name:Laboratoire HRA Pharma
    Full Title: " A Prospective, Randomized, Single Blind, Multicenter Study to Compare the Efficacy, Safety and Tolerability of CDB-2914 with Levonorgestrel as Emergency Contraception Within 120 Hours Unprotected...
    Medical condition: Emergency contraception
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: IE (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-000420-40 Sponsor Protocol Number: 310442 Start Date*: 2007-08-08
    Sponsor Name:Bayer Schering Pharma Oy
    Full Title: Multi-center, open-label, randomized study to assess the safety and contraceptive efficacy of two doses (in vitro 12 µg/24 h and 16 µg/24 h) of the ultra low dose levonorgestrel contraceptive intra...
    Medical condition: Contraception
    Disease: Version SOC Term Classification Code Term Level
    9.1 10010808 Contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: FI (Completed) SE (Completed) HU (Completed) FR (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2008-007024-26 Sponsor Protocol Number: BAY 86-5016/91557 Start Date*: 2009-04-27
    Sponsor Name:Bayer Healthcare AG
    Full Title: A single-center, open-label, crossover, randomized study to investigate the impact of the transdermal contraceptive patch containing 0.55 mg ethinylestradiol and 2.1 mg gestogene (material no. 8087...
    Medical condition: healthy volunteers
    Disease: Version SOC Term Classification Code Term Level
    9.1 10060346 Transdermal contraception LLT
    9.1 10030970 Oral contraception LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-000394-30 Sponsor Protocol Number: 309988 Start Date*: 2006-08-31
    Sponsor Name:Schering Oy
    Full Title: Multicenter study to investigate the bleeding profile and the insertion easiness in women inserted with a second consecutive MIRENA for contraception or menorrhagia
    Medical condition: Contraception or menorrhagia
    Disease: Version SOC Term Classification Code Term Level
    8.1 10010808 Contraception LLT
    Population Age: Adults Gender: Female
    Trial protocol: IE (Completed) FI (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2014-004677-17 Sponsor Protocol Number: 141022 Start Date*: 2016-02-29
    Sponsor Name:Kvinnokliniken, Universitetssjukhuset i Linköping, Landstinget i Östergötland
    Full Title: Contraception after gastric bypass - part 4 How does gastric bypass affect the pharmacocinetics of oral levonorgestrel?
    Medical condition: We want to investigate if the pharmacocinetics of levonorgestrel differs in women who have had bariatric surgery compared to women who have not. Measures of serum concentrations of levonorgestrel w...
    Disease: Version SOC Term Classification Code Term Level
    18.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    18.1 10042613 - Surgical and medical procedures 10061966 Gastric bypass PT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-000790-24 Sponsor Protocol Number: BEC01 Start Date*: 2020-07-14
    Sponsor Name:Universität Salzburg
    Full Title: BECONTRA - Effects of combined oral contraceptives on brain and behavior
    Medical condition: Girls and women 14 years - 35 years, considering the intake of COCs or under current use of EE/LNG or EE/CMA COCs
    Disease: Version SOC Term Classification Code Term Level
    21.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    20.0 10042613 - Surgical and medical procedures 10010808 Contraception PT
    22.0 10042613 - Surgical and medical procedures 10073728 Hormonal contraception PT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-019902-17 Sponsor Protocol Number: BAY86-5300/14701 Start Date*: 2010-12-09
    Sponsor Name:Bayer HealthCare AG
    Full Title: A multicenter, open-label, randomized, controlled, two-arm study to assess compliance with daily tablet intake of women on treatment with the oral contraceptive SH T00186D/BAY 86-5300 (0.02 mg ethi...
    Medical condition: Contraception
    Disease: Version SOC Term Classification Code Term Level
    12.1 10030970 Oral contraception LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) ES (Completed) GB (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2013-005234-37 Sponsor Protocol Number: CF111/304 Start Date*: 2014-05-28
    Sponsor Name:Laboratorios León Farma S.A.
    Full Title: Multicentre, Open-Label Trial to Assess the Safety and Tolerability of LF111 (Drospirenone 4.0 mg) Over 6 Cycles in Female Adolescents, With a 7-Cycle Extension Phase
    Medical condition: Oral contraception for postmenarcheal female adolescents, with or without intact hymen, aged 14-17 and without uncontrolled concomitant disease.
    Disease: Version SOC Term Classification Code Term Level
    18.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adolescents, Under 18 Gender: Female
    Trial protocol: DE (Completed) NL (Not Authorised) FI (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2010-023215-34 Sponsor Protocol Number: PSE-HSP-203 Start Date*: 2010-12-20
    Sponsor Name:Teva Women`s Health Research
    Full Title: A Multinational, Multicenter, Randomized, Open-Label Study to Evaluate the Impact of a 91-day Extended Cycle Oral Contraceptive Regimen, Compared to two 28-day Standard Oral Contraceptive Regimen...
    Medical condition: Healthy women taking contraceptive regimen
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030971 LLT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-005453-36 Sponsor Protocol Number: MPC134 Start Date*: 2009-02-19
    Sponsor Name:Central and North West London NHS Foundation Trust (Camden Provider Services)
    Full Title: The Effects of Standard vs. Tailored use of the Combined Oral Contraceptive on Continuation Rates at one year.
    Medical condition: A randomised controlled trial to find out whether tailored pill use is better than standard pill use by seeing which approach leads to more women staying on the pill for at least one year.
    Disease: Version SOC Term Classification Code Term Level
    13.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-002291-42 Sponsor Protocol Number: 308901 Start Date*: 2005-03-17
    Sponsor Name:Schering AG
    Full Title: Multi-center, open, randomized, dose finding phase II study to investigate for a maximum of three years ultra low dose levonorgestrel contraceptive intrauterine systems (LCS) releasing in vitro 12 ...
    Medical condition: Contraception
    Disease: Version SOC Term Classification Code Term Level
    7.0 10010808 LLT
    Population Age: Adults Gender: Female
    Trial protocol: FI (Completed) SE (Completed) HU (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2012-005797-58 Sponsor Protocol Number: 465 Start Date*: 2013-04-19
    Sponsor Name:Kvinnokliniken, Universitetessjukhuset i Linköping, landstinget i Östergötland
    Full Title: Contraception after gastric bypass - part three How does gastric bypass affect the pharmacocinetics of oral desogestrel?
    Medical condition: We want to investigate how the pharmacocinetics changes for Cerazette in 14 fertile obese women after, compared to before, bariatric surgery in forms of gastric by pass. Mesures of serum concetrati...
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    14.1 10042613 - Surgical and medical procedures 10061966 Gastric bypass PT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-012121-11 Sponsor Protocol Number: P06060 (299001) Start Date*: 2009-10-13
    Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation
    Full Title: A randomized, multicenter, explorative trial to explore the safety, acceptability and vaginal bleeding pattern of three doses of an etonogestrel-releasing medicated intrauterine system (ENG-MIUS) v...
    Medical condition: healthy parous women in need of contraception
    Disease: Version SOC Term Classification Code Term Level
    12.0 10010808 Contraception LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2010-021787-15 Sponsor Protocol Number: CF111/301 Start Date*: 2011-03-23
    Sponsor Name:Laboratorios León Farma S.A.
    Full Title: A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety and Tolerability of Drospirenone as LF111 During 13 Cycles
    Medical condition: Oral hormonal contraceptive for women without uncontrolled current diseases between 18-45 years.
    Disease: Version SOC Term Classification Code Term Level
    13.1 10042613 - Surgical and medical procedures 10010808 Contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) HU (Completed) CZ (Completed) RO (Completed)
    Trial results: View results
    EudraCT Number: 2011-002396-42 Sponsor Protocol Number: CF111/302 Start Date*: 2012-02-09
    Sponsor Name:Laboratorios León Farma S.A.
    Full Title: A Pivotal, Multicentre, Double-Blind, Double-Dummy, Randomised Trial on the Contraceptive Efficacy, Tolerability and Safety of LF111 (Drospirenone) Over 9 Cycles in Comparison With Desogestrel 0.07...
    Medical condition: Oral hormonal contraceptive for women without uncontrolled current diseases between 18-45 years.
    Disease: Version SOC Term Classification Code Term Level
    15.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) HU (Completed) CZ (Completed) AT (Completed) ES (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2019-001876-12 Sponsor Protocol Number: LPRI-424/301 Start Date*: 2019-12-16
    Sponsor Name:Chemo Research S.L.
    Full Title: A multicentre, uncontrolled trial on the contraceptive efficacy, safety, tolerability and pharmacokinetics of LPRI-424 (dienogest 2 mg / ethinyl estradiol 0.02 mg) during 13 cycles
    Medical condition: Oral contraception for females aged 18-45
    Disease: Version SOC Term Classification Code Term Level
    20.0 10042613 - Surgical and medical procedures 10042613 Surgical and medical procedures SOC
    21.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) LT (Completed) PT (Not Authorised) ES (Completed) BG (Completed) CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-014911-11 Sponsor Protocol Number: BAY86-5300/14567 Start Date*: 2010-06-18
    Sponsor Name:Bayer HealthCare AG
    Full Title: A multi-centre, randomized, double-blind, active control, parallel-group, 2-arm study to investigate the effect of ethinylestradiol / drospirenone / (0.02 mg/3 mg) oral contraception in a 24/4 regi...
    Medical condition: Oral Contraception
    Disease: Version SOC Term Classification Code Term Level
    14.0 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) PT (Completed) CZ (Completed) IT (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-004978-25 Sponsor Protocol Number: 300 Start Date*: 2006-09-06
    Sponsor Name:International Committee for Contraception Research of the Population Council
    Full Title: A multicenter, open-label study on the efficacy, cycle control and safety of a contraceptive vaginal ring delivering a daily dose of 150 µg of Nestorone(R) and 15 µg of ethinyl estradiol (150/15 NE...
    Medical condition: As the trial is intended to investigate a new contraceptive medicinal product, the study subjects included are not characterized by a specific medical condition.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10010808 Contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Ongoing) FI (Completed) HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-000925-30 Sponsor Protocol Number: 10 Start Date*: 2013-05-04
    Sponsor Name:Uppsala University
    Full Title: How common are mood and sexual side-effects from combined oral contraceptives?
    Medical condition: Healthy women
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2013-001091-38 Sponsor Protocol Number: SB011/02/2013 Start Date*: 2013-12-20
    Sponsor Name:sterna biologicals GmbH & Co. KG
    Full Title: A phase IIa, single-centre, randomised, vehicle-controlled, double-blind trial for assessment of efficacy, safety and tolerability of the topical formulation SB011 containing a human GATA-3 specifi...
    Medical condition: atopic eczema
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 08 07:31:48 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA